Medicare, Medicaid Drug Payment Models Get Designated Team At CMMI
Executive Summary
CMS’ innovation center creates new division to test alternative payment models, including likely new approaches for accelerated approval drugs and multi-state outcomes-based payment arrangements for cell and gene therapy in Medicaid.